0000818686 2026-09-10 2026-09-10 0000818686 1 2026-09-10 2026-09-10 0000818686 2 2026-09-10 2026-09-10 0000818686 3 2026-09-10 2026-09-10 0000818686 4 2026-09-10 2026-09-10 0000818686 5 2026-09-10 2026-09-10 iso4217:USD pure shares S-3 424B5 EX-FILING FEES 333-284770 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD N/A N/A S-3 TEVA PHARMACEUTICAL INDUSTRIES LTD false Debt EUR1,000,000,000 4.250% Senior Notes due 2033 true 1160000000 987.56 1145569600000.00 0.0001381 158203161.76 false Debt EUR500,000,000 5.625% Senior Notes due 2036 true 580000000 983.27 570296600000.00 0.0001381 78757960.46 false Debt $1,000,000,000 5.500% Senior Notes due 2034 true 1000000000 986.59 986590000000.00 0.0001381 136248079.00 false Debt $1,000,000,000 5.750% Senior Notes due 2037 true 1000000000 985.20 985200000000.00 0.0001381 136056120.00 false Debt $1,200,000,000 5.250% Senior Notes due 2032 true 1200000000 989.93 1187916000000.00 0.0001381 164051199.60 4875572200000.00 673316520.82 0.00 0.00 673316520.82 Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), based upon the euro/dollar rate of exchange of EUR1/$1.16 as of September 9, 2026, as reported by Bloomberg. Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), based upon the euro/dollar rate of exchange of EUR1/$1.16 as of September 9, 2026, as reported by Bloomberg. Calculated in accordance with Rule 457(r) under the Securities Act. Calculated in accordance with Rule 457(r) under the Securities Act. Calculated in accordance with Rule 457(r) under the Securities Act. 4875572200000.00 true